These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 7753801)

  • 21. Specific chemical dissociation of fibrillar and non-fibrillar components of amyloid deposits.
    Hind CR; Collins PM; Caspi D; Baltz ML; Pepys MB
    Lancet; 1984 Aug; 2(8399):376-8. PubMed ID: 6147456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid beta protein and the basis for Alzheimer's disease.
    Glenner GG
    Prog Clin Biol Res; 1989; 317():857-68. PubMed ID: 2690126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
    Maeda S
    Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloidosis.
    Hawkins PN
    Blood Rev; 1988 Dec; 2(4):270-80. PubMed ID: 3061533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
    Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
    Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoelectron microscopic localization of amyloid beta protein in the diffuse plaques of Alzheimer-type dementia.
    Yamaguchi H; Nakazato Y; Hirai S; Shoji M
    Brain Res; 1990 Feb; 508(2):320-4. PubMed ID: 2407313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis.
    Merlini G; Ascari E; Amboldi N; Bellotti V; Arbustini E; Perfetti V; Ferrari M; Zorzoli I; Marinone MG; Garini P
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2959-63. PubMed ID: 7708755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha 1-antichymotrypsin in brain aging and disease.
    Abraham CR; Potter H
    Prog Clin Biol Res; 1989; 317():1037-48. PubMed ID: 2513582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacy.
    Wall JS; Williams AD; Foster JS; Richey T; Stuckey A; Macy S; Wooliver C; Campagna SR; Tague ED; Farmer AT; Lands RH; Martin EB; Heidel RE; Kennel SJ
    Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10839-E10848. PubMed ID: 30377267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of complete screening for amyloid fibril type and systemic disease in patients with amyloidosis in the respiratory tract.
    Shah PL; Gillmore JD; Copley SJ; Collins JV; Wells AU; du Bois RM; Hawkins PN; Nicholson AG
    Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun; 19(2):134-42. PubMed ID: 12102609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.
    Tagliavini F; Giaccone G; Linoli G; Frangione B; Bugiani O
    Prog Clin Biol Res; 1989; 317():1001-5. PubMed ID: 2532368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular mechanism of fibril formation from serum amyloid A1 protein.
    Claus S; Meinhardt K; Aumüller T; Puscalau-Girtu I; Linder J; Haupt C; Walther P; Syrovets T; Simmet T; Fändrich M
    EMBO Rep; 2017 Aug; 18(8):1352-1366. PubMed ID: 28637682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trypsin interaction with the senile plaques of Alzheimer disease is mediated by beta-protein precursor.
    Smith MA; Dunbar CE; Miller EJ; Perry G
    Mol Chem Neuropathol; 1996 Feb; 27(2):145-54. PubMed ID: 8962599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer patients and Down patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques.
    Verga L; Frangione B; Tagliavini F; Giaccone G; Migheli A; Bugiani O
    Neurosci Lett; 1989 Nov; 105(3):294-9. PubMed ID: 2531851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene.
    Botto M; Hawkins PN; Bickerstaff MC; Herbert J; Bygrave AE; McBride A; Hutchinson WL; Tennent GA; Walport MJ; Pepys MB
    Nat Med; 1997 Aug; 3(8):855-9. PubMed ID: 9256275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer's disease.
    Chargé SB; Esiri MM; Bethune CA; Hansen BC; Clark A
    J Pathol; 1996 Aug; 179(4):443-7. PubMed ID: 8869295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Proteolysis in Amyloidosis.
    Acquasaliente L; De Filippis V
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum amyloid P component promotes formation of distinct aggregated lysozyme morphologies and reduces toxicity in Drosophila flies expressing F57I lysozyme.
    Bergkvist L; Richards DR; Bernardo-Gancedo A; Kumita JR; Nilsson PR; Brorsson AC
    PLoS One; 2020; 15(1):e0227227. PubMed ID: 31978114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.